| Literature DB >> 35177928 |
Xin Huang1, Yuan Liu2, Bo Guan1, Wenyi Yang1, Shasha Sun1, Jiakun Luo1, Yukun Luo3, Jian Cao1, Yujiao Deng3.
Abstract
AIM: To evaluate the left ventricular (LV) systolic function in elderly with non-ST elevation myocardial infarction (NSTEMI) and ST elevation myocardial infarction (STEMI) using real-time three-dimensional echocardiography (RT-3DE) and two-dimensional speckle tracking imaging (STI).Entities:
Keywords: acute myocardial infarction; echocardiography; elderly; left ventricular systolic function
Year: 2022 PMID: 35177928 PMCID: PMC8846626 DOI: 10.2147/IJGM.S348594
Source DB: PubMed Journal: Int J Gen Med ISSN: 1178-7074
Baseline Characteristics of the NSTEMI and STEMI Patients
| NSTEMI (n=40) | STEMI (n=40) | ||
|---|---|---|---|
| Age, years | 70.45 ± 4.08 | 71.07 ± 4.15 | 0.994 |
| Male | 27(67.5%) | 28(70%) | 0.809 |
| Heart rate | 83.69 ± 13.25 | 85.01 ± 12.93 | 0.6533 |
| Systolic blood pressure | 135.37 ± 14.68 | 137.42 ± 13.85 | 0.5225 |
| Diastolic blood pressure | 85.83 ± 9.41 | 84.19 ± 8.37 | 0.4127 |
| Diabetes mellitus | 14 (35%) | 12 (32.5%) | 0.633 |
| Hypertension | 31 (77.5%) | 32 (80%) | 0.785 |
| Dyslipidemia | 15 (37.5%) | 16 (40%) | 0.818 |
| Smoking | 18 (45%) | 21 (52.5%) | 0.502 |
| ACEI or ARB | 25 (62.5%) | 27 (67.5%) | 0.639 |
| Aspirin | 29 (72.5%) | 31(77.5%) | 0.606 |
| Statin | 20 (50%) | 23(57.5%) | 0.501 |
| Bata-blocker | 23(57.5%) | 24 (60%) | 0.820 |
| LAD disease | 11(27.5%) | 13(32.5%) | 0.626 |
| LCX disease | 7(17.5%) | 5(12.5%) | 0.531 |
| RCA disease | 4(10%) | 7(17.5%) | 0.330 |
| Multiple coronaries disease | 18 (45%) | 15(37.5%) | 0.496 |
Note: Values are expressed as the mean ± SD; *P< 0.05 vs NSTEMI group.
Abbreviations: ACEI, angiotensin-converting-enzyme inhibitor; ARB, angiotensin receptor blocker; NSTEMI, non-ST elevation myocardial infarction; STEMI, ST elevation myocardial infarction.
Left Ventricular Volume Function in Different Times
| Control (n=40) | NSTEMI (n=40) | STEMI (n=40) | |||
|---|---|---|---|---|---|
| 1 Week After PCI | 3 Months After PCI | 1 Week After PCI | 3 Months After PCI | ||
| LVEDV (mL) | 84.65 ± 7.33 | 93.23 ± 8.01* | 86.13 ± 6.85# | 101.95 ± 28.12*† | 94.46 ± 22.97*#† |
| LVESV (mL) | 30.68 ± 6.85 | 46.78 ± 7.09* | 33.09 ± 5.21# | 55.08 ± 13.87*† | 43.75 ± 13.63*#† |
| LVSV (mL) | 54.03 ± 7.23 | 46.19 ± 9.01* | 51.64 ± 7.74# | 45.62 ± 13.35* | 50.97 ± 12.70 |
| LVEF (%) | 63.71 ± 2.63 | 49.53 ± 5.14* | 58.64 ± 3.26*# | 45.54 ± 4.50*† | 53.89 ± 4.24*#† |
Notes: Values are expressed as the mean ± SD; *P < 0.05 vs control group; #P < 0.05 vs 1 week after PCI; †P < 0.05 vs NSTEMI (in the same time).
Abbreviations: LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LVSV, left ventricular stroke volume; LVEF, left ventricular ejection fraction; NSTEMI, non-ST elevation myocardial infarction; STEMI, ST elevation myocardial infarction.
Figure 1(A) LPSS- time curve and Bull’s-eye strain map in the control group. (B) NSTEMI patients LPSS-time curve and Bull’s-eye strain map in 1 week after PCI. (C) NSTEMI patients LPSS-time curve and Bull’s-eye strain map in 3 months after PCI. (D) STEMI patients LPSS-time curve and Bull’s-eye strain map in 1 week after PCI. (E) STEMI patients LPSS-time curve and Bull’s-eye strain map in 3 months after PCI.
The LV Multi-Dimensional Strain in the Elderly STEMI and NSTEMI Patients
| Control (n=40) | NSTEMI (n=40) | STEMI (n=40) | |||
|---|---|---|---|---|---|
| 1 Week After PCI | 3 Months After PCI | 1 Week After PCI | 3 Months After PCI | ||
| LPSS (Myo-IRA) | |||||
| Basal segments (%) | −21.39 ± 2.87 | −13.08 ± 2.76* | −16.49 ± 3.21*# | 11.17 ± 4.23*† | −12.30 ± 3.42*† |
| Middle segments (%) | −22.16 ± 2.91 | −12.34 ± 4.02* | −16.45 ± 3.11*# | −10.89 ± 3.67*† | −12.17 ± 3.59*† |
| Apical segments (%) | −24.76 ± 2.68 | −13.11 ± 3.17* | −16.76 ± 3.09*# | −11.28 ± 3.75*† | −12.45 ± 3.32*† |
| RPSS (Myo-IRA) | |||||
| Basal segments (%) | 35.63 ± 14.21 | 19.31 ± 11.70* | 32.10 ± 13.26# | 16.08 ± 9.57* | 24.92 ±11.57*#† |
| Middle segments (%) | 49.81 ± 14.93 | 20.28 ± 13.41* | 34.71 ± 15.10*# | 16.54 ± 10.46* | 25.18 ± 13.51*#† |
| Apical segments (%) | 30.31 ± 11.69 | 16.89 ± 12.21* | 25.68 ± 13.00*# | 14.17 ± 9.89* | 19.27 ± 10.08*#† |
| CPSS (Myo-IRA) | |||||
| Basal segments (%) | −21.93 ± 3.00 | −15.01 ± 3.10* | −19.83 ± 3.15*# | −13.13 ± 3.01*† | −16.64 ± 2.96*#† |
| Middle segments (%) | −22.18 ± 3.26 | −14.73 ± 3.25* | −20.01 ± 3.31*# | −12.49 ± 2.94*† | −16.25 ± 3.13*#† |
| Apical segments (%) | −25.10 ± 3.21 | −15.51 ± 3.17* | −19.87 ± 3.06*# | −13.09 ± 3.11*† | −16.55 ± 3.12*#† |
| Rot | |||||
| Basal segments (°) | −8.89± 2.16 | −5.98 ± 2.55* | −7.21 ± 2.61*# | −5.14 ± 2.69*† | −6.67± 3.05*#† |
| Apical segments (°) | 12.58 ± 2.96 | 6.49 ± 2.91* | 10.87 ± 3.06*# | 5.40 ± 2.94*† | 6.23 ± 3.60*#† |
| Twist (°) | 21.46 ± 3.05 | 12.47 ±3.29* | 17.98 ± 3.16*# | 10.55 ± 2.90*† | 12.91 ± 3.23*#† |
Notes: Values are expressed as the mean ± SD; *P < 0.001 vs control group; #P < 0.01 vs one week after PCI (in the same group); †P < 0.05 vs NSTEMI (in the same time).
Abbreviations: NSTEMI, non-ST elevation myocardial infarction; STEMI, ST elevation myocardial infarction; LPSS, longitudinal peak systolic strain; RPSS, radial peak systolic strain; CPSS, circumferential peak systolic strain.
Figure 2(A) LV Rot-Api and Rot-Bas and Twist in control group. (B) NSTEMI patients LV Rot-Api, Rot-Bas and Twist in 1 week after PCI. (C) NSTEMI patients LV Rot-Api, Rot-Bas and Twist in 3 months after PCI. (D) STEMI patients LV Rot-Api, Rot-Bas and Twist in 1 week after PCI. (E) STEMI patients LV Rot-Api, Rot-Bas and Twist in 3 months after PCI.